Drugmaker to Offer Early Access to Experimental GLP-1 Retatrutide
Eli Lilly, the drugmaker behind the GLP-1 drugs Mounjaro and Zepbound, will allow a limited number of adults with severe obesity to seek early access to retatrutide , its experimental…